NIH-funded research NIH-funded research

Developing a new treatment for aldicarb poisoning

Official title: Long-acting aldicarb hydrolase as a medical countermeasure for aldicarb poisoning

Funded at University of Kentucky · NIH-10917295 · Data updated 2026-11-12

This study is working on a new treatment that helps people who have been exposed to a dangerous pesticide called aldicarb, by creating a special enzyme that can help restore the body's ability to function normally after exposure.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Kentucky
NIH-funded
Lab location1 site (Lexington, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2025
Funding year2024
Award (this year)$532,962
NIH project number5UG3NS134920-02
Project IDNIH-10917295 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research would include individuals who have been exposed to aldicarb or are at risk of exposure due to environmental or occupational factors.

Less likely to help

Patients who have not been exposed to aldicarb or who have other unrelated medical conditions may not benefit from this research.

What this research studies

This research focuses on creating a long-acting enzyme that can effectively counteract the toxic effects of aldicarb, a highly toxic pesticide. The approach involves understanding how aldicarb inhibits a critical enzyme in the body, acetylcholinesterase, and developing a medical countermeasure that can restore its function. By using advanced biochemical techniques, the research aims to improve treatment options for individuals exposed to aldicarb, particularly in emergency situations. The study will involve both laboratory experiments and potential animal models to evaluate the effectiveness of the new treatment.

Why it matters

Potential benefit: If successful, this research could provide a more effective treatment for patients suffering from aldicarb poisoning, potentially saving lives and improving recovery outcomes.

How similar studies have gone: While there has been significant research on treatments for organophosphate poisoning, this specific approach to aldicarb poisoning is relatively novel and has not been extensively tested.

Where this research is happening

  • University of Kentucky
    Lexington, United States
    Active

Researchers

  • Principal investigator: Zheng, Fang — University of Kentucky
  • Study coordinator: Zheng, Fang

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.